These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17276935)

  • 1. A Review of beta2 -glycoprotein-l antibody testing results from a peer-driven multilaboratory quality assurance program.
    Favaloro EJ; Wong RC; Jovanovich S; Roberts-Thomson P
    Am J Clin Pathol; 2007 Mar; 127(3):441-8. PubMed ID: 17276935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multilaboratory peer assessment quality assurance program-based evaluation of anticardiolipin antibody, and beta2-glycoprotein I antibody testing.
    Favaloro EJ; Wong RC; Silvestrini R; McEvoy R; Jovanovich S; Roberts-Thomson P
    Semin Thromb Hemost; 2005 Feb; 31(1):73-84. PubMed ID: 15706478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the usefulness of anticardiolipin antibody assays: a cautious approach is suggested by high variation and limited consensus in multilaboratory testing.
    Favaloro EJ; Silvestrini R
    Am J Clin Pathol; 2002 Oct; 118(4):548-57. PubMed ID: 12375642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-beta2-Glycoprotein I activity.
    Pengo V; Biasiolo A; Bison E; Chantarangkul V; Tripodi A;
    Thromb Res; 2007; 120(1):127-33. PubMed ID: 17020782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Internal quality control and external quality assurance in testing for antiphospholipid antibodies: Part I--Anticardiolipin and anti-β2-glycoprotein I antibodies.
    Favaloro EJ; Wheatland L; Jovanovich S; Roberts-Thomson P; Wong RC
    Semin Thromb Hemost; 2012 Jun; 38(4):390-403. PubMed ID: 22570184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of the first fully automated method for anti-cardiolipin and anti-beta2 glycoprotein I antibody detection for the diagnosis of antiphospholipid syndrome.
    Villalta D; Alessio MG; Tampoia M; Da Re A; Stella S; Da Re M; Tozzoli R; Bizzaro N
    Ann N Y Acad Sci; 2009 Sep; 1173():21-7. PubMed ID: 19758127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-beta2-glycoprotein I in childhood immune thrombocytopenic purpura.
    El-Bostany EA; El-Ghoroury EA; El-Ghafar EA
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):26-31. PubMed ID: 18180612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations--a cooperative project of the European Antiphospholipid Forum.
    Tincani A; Allegri F; Sanmarco M; Cinquini M; Taglietti M; Balestrieri G; Koike T; Ichikawa K; Meroni P; Boffa MC
    Thromb Haemost; 2001 Aug; 86(2):575-83. PubMed ID: 11522006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technical aspects in laboratory testing for antiphospholipid antibodies: is standardization an impossible dream?
    Reber G; Boehlen F; de Moerloose P
    Semin Thromb Hemost; 2008 Jun; 34(4):340-6. PubMed ID: 18814067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inter-laboratory variability of anti-beta2-glycoprotein I measurement. A collaborative study in the frame of the European Forum on Antiphospholipid Antibodies Standardization Group.
    Reber G; Schousboe I; Tincani A; Sanmarco M; Kveder T; de Moerloose P; Boffa MC; Arvieux J
    Thromb Haemost; 2002 Jul; 88(1):66-73. PubMed ID: 12152681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-cardiolipin antibody testing and reporting practices among laboratories participating in a large external Quality Assurance Program.
    Wong R; Wilson R; Pollock W; Steele R; Gillis D
    Pathology; 2004 Apr; 36(2):174-81. PubMed ID: 15203755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to the atheroma component beta2-glycoprotein I and risk of symptomatic peripheral artery disease.
    Franck M; Staub HL; Petracco JB; Norman GL; Lassen AJ; Schiavo N; Borges RB; von Mühlen CA
    Angiology; 2007; 58(3):295-302. PubMed ID: 17626983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A consensus approach to the formulation of guidelines for laboratory testing and reporting of antiphospholipid antibody assays.
    Wong RC; Favaloro EJ
    Semin Thromb Hemost; 2008 Jun; 34(4):361-72. PubMed ID: 18814070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and clinical significance of anticardiolipin, anti-beta2-glycoprotein-1, and anti-heat shock protein-70 autoantibodies in sudden sensorineural hearing loss.
    Gross M; Eliashar R; Ben-Yaakov A; Ulmansky R; Elidan J
    Audiol Neurootol; 2008; 13(4):231-8. PubMed ID: 18259075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus guidelines for anticardiolipin antibody testing.
    Wong RC;
    Thromb Res; 2004; 114(5-6):559-71. PubMed ID: 15507292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multi-centre evaluation of the intra-assay and inter-assay variation of commercial and in-house anti-cardiolipin antibody assays.
    Wong R; Favaloro E; Pollock W; Wilson R; Hendle M; Adelstein S; Baumgart K; Homes P; Smith S; Steele R; Sturgess A; Gillis D
    Pathology; 2004 Apr; 36(2):182-92. PubMed ID: 15203756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with atherosclerotic syndrome, negative in anti-cardiolipin assays, make IgA autoantibodies that preferentially target domain 4 of beta2-GPI.
    Iverson GM; von Mühlen CA; Staub HL; Lassen AJ; Binder W; Norman GL
    J Autoimmun; 2006 Dec; 27(4):266-71. PubMed ID: 17081732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-beta(2)-glycoprotein I autoantibody expression as a potential biomarker for strokes in patients with anti-phospholipid syndrome.
    Ali HY; Abdullah ZA
    J Immunotoxicol; 2008 Apr; 5(2):173-7. PubMed ID: 18569388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
    Sahin M; Duzgun N; Tunc SE; Tutkak H
    Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.